Both in Pharmaceuticals
Tango Therapeutics vs AbCellera Biologics
Over the past year TNGX returned +189.3% and ABCL returned +126.8%; their daily moves had a correlation of 0.20.
TNGX +189.3% ABCL +126.8%Growth of $1, one year, split-adjusted
| Metric | TNGX | ABCL |
|---|---|---|
| Price | $23.17 | $12.18 |
| Market cap | $3.91B | $3.95B |
| Today | +6.48% | +9.53% |
| 1 month | +0.4% | −11.6% |
| 6 months | −4.3% | +161.4% |
| Year to date | +161.5% | +256.1% |
| 1 year | +185.7% | +119.5% |
| Revenue growth (YoY) | −100.0% | −76.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −1368.6% |
| P/E (TTM) | — | — |
| Price / sales | 72.6× | 59.6× |
| Net cash | $1.01B | $540.1M |
| Dividend yield | — | — |
| Volatility (60d) | 73.2% | 78.1% |
| Short % of float | 31.9% | 14.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).